DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...

Narrow-moat Icon is continuing to work through a challenging macroeconomic environment, as some of its customers are undergoing budget cuts and reprioritizations of their pipeline candidates. However, ...

Icon ICLR reported strong fourth-quarter results highlighted by revenue of $1.9 billion, representing an increase of 4% from the prior-year period. Full-year revenue of $7.7 billion represented an ...

Stock-based compensation expense represents the amount of recurring expense related to the company’s equity compensation programs (inclusive of employer related taxes). (b) Foreign currency ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icon ( (ICLR)) has issued an announcement ...

Icon PLC (ICLR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

Icon Plc ( (ICLR)) has released its Q3 earnings. Here is a breakdown of the information Icon Plc presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is ...